Patents by Inventor Guojie Wu

Guojie Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSION PROTEINS
    Publication number: 20240100134
    Abstract: The present invention relates to chimeric and fusion proteins and their compositions, and the use of such proteins and compositions in the prevention and/or treatment diseases or conditions requiring plasminogen supplementation. In one aspect, the invention provides a chimeric or fusion protein comprising plasminogen and an Fc region of an antibody.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 28, 2024
    Applicant: Monash University
    Inventors: James C. Whisstock, Ruby HP Law, Adam J. Quek, Christoph Hagemeyer, Mikael Martino, Guojie Wu, Yen-Zhen Lu
  • ANTIBODIES FOR BINDING PLASMIN
    Publication number: 20230220112
    Abstract: The present invention provides an antigen binding protein comprising an antigen binding domain that binds to plasmin, wherein the antigen binding protein reduces the activity of plasmin. The invention also provides compositions comprising the antigen binding protein, and uses and method of treatment comprising the same.
    Type: Application
    Filed: October 28, 2020
    Publication date: July 13, 2023
    Inventors: James Whisstock, Ruby Law, Adam Quek, Paul Conroy, Guojie Wu
  • ANTIBODIES FOR BINDING PLASMINOGEN
    Publication number: 20220380484
    Abstract: The present invention relates to antigen binding proteins comprising an antigen binding domain that binds to plasminogen, wherein the antigen binding protein reduces the activation of plasminogen to plasmin, pharmaceutical compositions comprising the same, and methods and uses thereof.
    Type: Application
    Filed: October 28, 2020
    Publication date: December 1, 2022
    Inventors: James Whisstock, Ruby Law, Adam Quek, Paul Conroy, Dena Lyras, Guojie Wu
  • Polymorphic form of montelukast sodium
    Patent number: 7560559
    Abstract: The invention provides novel polymorphic form of montelukast sodium, as well as methods of using and pharmaceutical compositions containing saud novel form. Also provided are montelukast sodium: acetonitrile solvates, which are intermediates in the formation of crystalline montelukast sodium.
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: July 14, 2009
    Assignees: Merck & Co., Inc., Merck Frosst Canada & Co.
    Inventors: Jun-Hong Chou, Michael B. Gentzler, James N. Michaels, Cynthia Bazin, Sophie-Dorothee Clas, Chad Dalton, Michael Guojie Wu